Flerie

FLERIE · Nasdaq Stockholm · Healthcare

16.10SEK 0.0%last day

Price as of 2 October 2026

The price over the past year, with dividends: −56.6%

Performance

1 month

−11.8%

1 year

−56.6%

3 years, per year

+1,113.9%

5 years, per year

+297.6%

Largest fall, 3 years

−67.0%

Below the peak now

−67.0%

Volatility, 1 year

32.4%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

0.4

Dividend yield

0.0%

Return on equity

−24.6%

Net margin

−52.1%

Market value

146 m USD

Quality, value and trend

Where Flerie stands against every Nordic stock today. 100 is best.

Quality29

Profitability and a sound balance sheet over time. Better than 29% of Nordic stocks.

Value23

The price measured against earnings, assets and cash flow. Better than 23% of Nordic stocks.

Trend6

The price development over the past year. Better than 6% of Nordic stocks.

Combined4

Quality, value and trend together. Better than 4% of Nordic stocks.

About Flerie

Flerie is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 2 employees.

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis